These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 19037176

  • 1. Effectiveness of long-term augmentation with citalopram to clomipramine in treatment-resistant OCD patients.
    Marazziti D, Golia F, Consoli G, Presta S, Pfanner C, Carlini M, Mungai F, Catena Dell'osso M.
    CNS Spectr; 2008 Nov; 13(11):971-6. PubMed ID: 19037176
    [Abstract] [Full Text] [Related]

  • 2. Citalopram for treatment-resistant obsessive-compulsive disorder.
    Pallanti S, Quercioli L, Paiva RS, Koran LM.
    Eur Psychiatry; 1999 Apr; 14(2):101-6. PubMed ID: 10572334
    [Abstract] [Full Text] [Related]

  • 3. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
    Pallanti S, Quercioli L, Koran LM.
    J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120
    [Abstract] [Full Text] [Related]

  • 4. Obsessive-compulsive disorder: an open-label pilot trial of escitalopram.
    Galvão-de Almeida A, Quarantini LC, Góis CR, Santos-Jesus R, Miranda-Scippa AM, de Oliveira IR, da Silva Prado H, Leckman JF, Rosário MC.
    CNS Spectr; 2007 Jul; 12(7):519-24. PubMed ID: 17603402
    [Abstract] [Full Text] [Related]

  • 5. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
    Tundo A, Salvati L, Busto G, Di Spigno D, Falcini R.
    J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
    [Abstract] [Full Text] [Related]

  • 6. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
    Zohar J, Judge R.
    Br J Psychiatry; 1996 Oct; 169(4):468-74. PubMed ID: 8894198
    [Abstract] [Full Text] [Related]

  • 7. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L.
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [Abstract] [Full Text] [Related]

  • 8. Clinical predictors of drug response in obsessive-compulsive disorder.
    Erzegovesi S, Cavallini MC, Cavedini P, Diaferia G, Locatelli M, Bellodi L.
    J Clin Psychopharmacol; 2001 Oct; 21(5):488-92. PubMed ID: 11593074
    [Abstract] [Full Text] [Related]

  • 9. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL, Jakubovski E, Bloch MH.
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
    [Abstract] [Full Text] [Related]

  • 10. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
    Simpson HB, Foa EB, Liebowitz MR, Ledley DR, Huppert JD, Cahill S, Vermes D, Schmidt AB, Hembree E, Franklin M, Campeas R, Hahn CG, Petkova E.
    Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
    [Abstract] [Full Text] [Related]

  • 11. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).
    Alaghband-Rad J, Hakimshooshtary M.
    Eur Child Adolesc Psychiatry; 2009 Mar; 18(3):131-5. PubMed ID: 19190958
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.
    Koponen H, Lepola U, Leinonen E, Jokinen R, Penttinen J, Turtonen J.
    Acta Psychiatr Scand; 1997 Nov; 96(5):343-6. PubMed ID: 9395151
    [Abstract] [Full Text] [Related]

  • 16. Citalopram in refractory obsessive-compulsive disorder: an open study.
    Marazziti D, Dell'Osso L, Gemignani A, Ciapparelli A, Presta S, Nasso ED, Pfanner C, Cassano GB.
    Int Clin Psychopharmacol; 2001 Jul; 16(4):215-9. PubMed ID: 11459335
    [Abstract] [Full Text] [Related]

  • 17. Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
    Pallanti S, Quercioli L, Bruscoli M.
    J Clin Psychiatry; 2004 Oct; 65(10):1394-9. PubMed ID: 15491244
    [Abstract] [Full Text] [Related]

  • 18. Drug treatment of obsessive-compulsive disorder (OCD): long-term trial with clomipramine and selective serotonin reuptake inhibitors (SSRIs).
    Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G.
    Psychopharmacol Bull; 1996 Oct; 32(1):167-73. PubMed ID: 8927668
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacologic therapy of obsessive compulsive disorder.
    DeVeaugh-Geiss J.
    Adv Pharmacol; 1994 Oct; 30():35-52. PubMed ID: 7833296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.